• Home
  • Contact

Researchers culture novel coronavirus, may help in drug testing and vaccine development

Biotech Today — May 27, 2020 in News 10 Likes 195 Views Share TwitterTweet on Twitter FacebookShare on Facebook Google+Google+ PinterestPinterest

The Centre for Cellular and Molecular Biology (CCMB) has established stable cultures of novel coronavirus from patients’ samples.

The post Researchers culture novel coronavirus, may help in drug testing and vaccine development appeared first on BioTech Times.

Source

CCMB Cell Culture Coronavirus drug News Novel Coronavirus Research Vaccine

About the Author: Biotech Today

You might like

Finnish and US companies form exclusive agreement for development of sustained release drug

11 hours ago 0 Likes 1

Exyte Builds mRNA Competence Center for WACKER in Germany

13 hours ago 0 Likes 1

New discovery center to house scientists opens in India

17 hours ago 0 Likes 1

The five most advanced microbiome players aiming for the gut

17 hours ago 0 Likes 1

AstraZeneca adds to its treatments for blood cancer with $100M deal

1 day ago 0 Likes 1

Positive news from trial for drug to treat major depressive disorder

1 day ago 0 Likes 1
[cm_ad_changer group_id="3"]

Recent Posts

  • Finnish and US companies form exclusive agreement for development of sustained release drug
  • Exyte Builds mRNA Competence Center for WACKER in Germany
  • New discovery center to house scientists opens in India
  • The five most advanced microbiome players aiming for the gut
  • AstraZeneca adds to its treatments for blood cancer with $100M deal
  • Positive news from trial for drug to treat major depressive disorder
  • Sanofi Global Health launches 30 nonprofit medicines in low-income countries
  • Destiny Pharma announces start of new oral mucositis research program
  • Poxel publishes ALD studies
  • Novartis Pharmaceuticals UK launches health-tech investor partnership for cardiovascular care
[cm_ad_changer group_id="4"]
[cm_ad_changer group_id="5"]
© 2020 biotechTODAY - Designed by Legendary Group